190 results on '"Wan, Siu-Hin"'
Search Results
2. Outcomes of Patients With Diabetes Versus Patients Without Diabetes Hospitalized With Acute Heart Failure
3. First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension
4. Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP
5. Comparing the influence of 2009 versus 2016 ASE/EACVI diastolic function guidelines on the prevalence and echocardiographic characteristics of preclinical diastolic dysfunction (stage B heart failure) in a Hispanic population with type 2 diabetes mellitus
6. The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study
7. Natriuretic Peptides: Physiology for the Clinician
8. Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure)
9. 77-Year-Old Man With Hypothyroidism, Right Upper Quadrant Pain, and Diarrhea
10. 44-Year-Old Man With Abdominal Pain, Fever, and Bloody Diarrhea
11. 83-Year-Old Man With Chest Pain, Exertional Dyspnea, and Anemia
12. Safety and blood pressure trajectory of short-term withdrawal of antihypertensive medications in older adults: Experience from a clinical trial sample
13. Abstract 17555: Healthcare Disparities in Heart Failure: Identifying the Burden and Predictors of Preclinical Diastolic Dysfunction (Stage B Heart Failure) in a Hispanic Population With Type 2 Diabetes Mellitus
14. Targeting Preclinical Diastolic Dysfunction to Prevent Heart Failure: Contemporary Insights
15. Validation of the WATCH‐DM and TRS‐HF DM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis
16. Insulin Therapy is Associated With Increased Myocardial Interstitial Fibrosis and Cardiomyocyte Apoptosis in a Rodent Model of Experimental Diabetes
17. Maskophobia As A Cause Of Non-exertional Dyspnea In The Era Of Covid-19
18. Cardiorenal Effects of Long‐Term Phosphodiesterase V Inhibition in Pre–Heart Failure
19. Pericardial Effusion Following Drain Removal after Percutaneous Epicardial Access for an Electrophysiology Procedure
20. Annexin A1 is a Potential Novel Biomarker of Congestion in Acute Heart Failure
21. Obesity Does Not Increase Complication Rate of Percutaneous Epicardial Access
22. Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction
23. Cardiovascular Manifestations of COVID-19
24. THE HEMODYNAMIC GAIN INDEX AND CARDIORESPIRATORY FITNESS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION - INSIGHTS FROM RELAX
25. Targeting the nitrate–nitrite–nitric oxide pathway in heart failure with preserved ejection fraction: too soon to say no to nitric oxide?
26. Acute Polyarticular Gout Presenting as Delirium
27. Validation of the WATCH-DM and TRS-HFDM Risk Scores to Predict the Risk of Incident Hospitalization for Heart Failure Among Adults With Type 2 Diabetes: A Multicohort Analysis.
28. Life and Death, Hope and Despair in the Era of Coronavirus Disease 2019
29. Constrictive Pericarditis After Lung Transplantation
30. A 61-Year-Old Woman With New Pericardial Effusion
31. A Contemporary Systematic Approach to Assessing the Patient with Heart Failure with Reduced Ejection Fraction: Multimodal Noninvasive and Invasive Evaluation
32. Predictive Value of the Get With The Guidelines Heart Failure Risk Score in Unselected Cardiac Intensive Care Unit Patients
33. Transcatheter aortic valve replacement valve in transcatheter aortic valve replacement valve for severe periprosthetic regurgitation
34. Differential Prevalence and Predictors of Preclinical Diastolic Dysfunction in a Hispanic Population with Type 2 Diabetes Mellitus Based on 2009 versus 2016 ASE Diastolic Function Guidelines
35. INSULIN THERAPY IN A RAT MODEL OF DIABETIC CARDIOMYOPATHY IS ASSOCIATED WITH ATTENUATION OF THE CGMP SYSTEM
36. ANNEXIN A1 A NOVEL BIOMARKER FOR CONGESTION IN ACUTE HEART FAILURE?
37. Implantation of leadless pacemaker for the development of new left bundle branch block and symptomatic pause following transcatheter aortic valve replacement
38. Prognostic Impact of Fasting Plasma Glucose on Mortality and Re-Hospitalization in Patients with Acute Heart Failure
39. The Bionic Man: Surgical and Percutaneous Advances in Heart Failure and D-transposition of the Great Arteries
40. Lethal Combination of Clenbuterol and Taurine in a Young Body-Builder
41. Future of Quantitative Echocardiography for Trainees
42. Insulin Treatment is Associated with Increased Cardiorenal Fibrosis Despite Maintaining Euglycemia in Experimental Diabetic Cardiomyopathy
43. Takotsubo cardiomyopathy: etiology, diagnosis, and optimal management
44. Delayed post-operative cardiac tamponade manifesting as cardiogenic shock
45. Experimental Model of Type 2 Diabetic Cardiomyopathy: A State of cGMP Deficiency
46. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction
47. DIFFERENTIAL CLINICAL OUTCOMES IN DIABETIC VERSUS NON-DIABETIC PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE AND DIASTOLIC DYSFUNCTION: A POPULATION BASED STUDY
48. Abstract 14274: Characteristics and Natural History of Hospitalized Heart Failure Patients With Diabetes Mellitus: Preserved versus Reduced Ejection Fraction
49. The Preoperative Evaluation of Infective Endocarditis via 3-Dimensional Transesophageal Echocardiography
50. GLYCOGEN STORAGE DISEASE INDUCED RESTRICTIVE CARDIOMYOPATHY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.